107 results
Page 4 of 6
8-K
EX-99.1
6yfoz8 n9zh5x9s
12 Nov 20
Akero Therapeutics Reports THIRD Quarter 2020 Financial Results
4:20pm
8-K
EX-99.1
4e82j a4ugl
15 Oct 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation October 2020
8:30am
8-K
EX-99.1
lhow2989c7b mq9ig
12 Aug 20
Akero Therapeutics Reports SECOND Quarter 2020 Financial Results
4:25pm
424B4
f0iw1s4kmlp06qw70xv6
8 Jul 20
Prospectus supplement with pricing info
8:30pm
S-3
l1o ubt58
1 Jul 20
Shelf registration
4:08pm
8-K
EX-99.2
jot93vvn256
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm
8-K
EX-99.1
pcpvtqqw2w
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm
8-K
uq9b rf1i5a
2 Jun 20
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
EX-99.1
26r6fh4v150jxyov9t1u
28 May 20
Other Events
8:01am
DRS
7fgd89qhju41q
15 May 20
Draft registration statement
12:00am
8-K
EX-99.1
xmzglvlhmdim th
13 May 20
Akero Therapeutics Reports first Quarter 2020 Financial Results
4:17pm
DEF 14A
c8hcay
27 Apr 20
Definitive proxy
7:30am
8-K
EX-99.1
s2nak1
31 Mar 20
Regulation FD Disclosure
8:25am
10-K
EX-10.12
l4izt937o
16 Mar 20
Annual report
5:17pm
10-K
bf9nmbi917y6
16 Mar 20
Annual report
5:17pm
8-K
EX-99.1
uiectxr
16 Mar 20
Akero Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
7:45am
8-K
EX-99.1
bjj1z 6qk
13 Jan 20
Other Events
8:06am